View the latest SAMU supported publications from 2021
Articles include:
From Q1:
- Treatment outcomes of children and adolescents receiving drug-resistant TB treatment in a routine TB programme, Mumbai, India
- “It’s a secret between us”: a qualitative study on children and care-giver experiences of HIV disclosure in Kinshasa, Democratic Republic of Congo
- Tuberculosis preventive therapy for children and adolescents: an emergency response to the COVID-19 pandemic
- A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients
- Challenging drug-resistant TB treatment journey for children, adolescents and their care-givers: A qualitative study
From Q2:
- What gaps remain in the HIV cascade of care? Results of a population- based survey in Nsanje District, Malawi
- A positive COVID-19 test is associated with high mortality in RR-TB-HIV patients
- Community-based TB testing as an essential part of TB recovery plans in the COVID-19 era
- Treating Drug-resistant Tuberculosis Infection: No More Excuses
- High Prevalence of NRTI and NNRTI Drug Resistance Among ART-Experienced, Hospitalized Inpatients
- OCB Medical Activity Report 2020
From Q3:
- The HIV cascade of care among serodiscordant couples in four high HIV prevalence settings in sub-Saharan Africa
- Correction to: Delivering PrEP to Young Women in a Low‑Income Setting in South Africa: Lessons for Providing Both Convenience and Support
- A home-based care programme for rifampicin-resistant TB
- Delivering PrEP to Young Women in a Low‑Income Setting in South Africa: Lessons for Providing Both Convenience and Support
- High Prevalence of NRTI and NNRTI Drug Resistance Among ART-Experienced, Hospitalized Inpatients
- Virologic efficacy of tenofovir, lamivudine and dolutegravir as second-line antiretroviral therapy in adults failing a tenofovir-based first-line regimen
- Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19
- Slipping through the cracks: a qualitative study to explore pathways of HIV care and treatment amongst hospitalised patients with advanced HIV in Kenya and the Democratic Republic of the Congo
- Rifampicin mono-resistant tuberculosis is not the same as multidrug-resistant tuberculosis: a descriptive study from Khayelitsha, South Africa